This clinical trial is for adults with certain advanced cancers, like liver, cervical, and breast cancer. They're studying a new treatment using two medicines, DB-1311 combined with BNT327 or DB-1305. This trial will check if these medicines are safe and work well together.
Participants need to have at least one tumor that can be measured and be healthy enough to participate, as determined by a doctor. They should also have stopped any previous treatments for a while before joining. The trial does not accept people with certain health issues, like severe heart disease or brain metastases, which means cancer has spread to the brain.
Key Points:- Participants must be 18 or older and have a life expectancy of at least 3 months.
- There are specific requirements for each type of cancer involved in the study.
- This is an open-label study, meaning both doctors and participants know what treatment is being given.
How understandable was the trial content above?
Hard to understand
Easy to understand